Latest Breaking News On - Global rare - Page 3 : comparemela.com

Chiesi Global Rare Diseases Announces U S Networkwide Sponsorship of BioInnovation Labs

Chiesi Global Rare Diseases Announces U S Networkwide Sponsorship of BioInnovation Labs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomBaden wübergFrance generalUnited statesVeena krishnappaAdam daleyGiacomo chiesiChiesi groupB corpBerry company public relationsGlobal rare diseasesBioinnovation labsStrategic innovation unitBenefit corporationChiesi global rareGolden tickets

Chiesi Global Rare Diseases Announces Collaboration with the National Alliance on Mental Illness to Offer Mental Health Resources for Fabry Disease

/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected.

United kingdomUnited statesGiacomo chiesiJessica edwardsNational alliance on mental illnessChiesi groupB corpBerry company public relationsGlobal rare diseasesNational allianceMental illnessChiesi global rareDevelopment officer jessicaChiesi global rare diseasesBenefit corporationGlobal rare

Chiesi Global Rare Diseases Announces Approval of FERRIPROX™ MR Deferiprone Extended-Release Tablets in Canada

Chiesi Global Rare Diseases Announces Approval of FERRIPROX™ MR Deferiprone Extended-Release Tablets in Canada
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAdam daleyGiacomo chiesiHealth canadaB corpChiesi groupBerry company public relationsGlobal rare diseasesChiesi global rareMore informationProduct monographGlobal rare

Chiesi Global Rare Diseases Announces Approval of FERRIPROX™ MR Deferiprone Extended-Release Tablets in Canada

New formulation allows twice-daily dosing in patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy.

United kingdomUnited statesAdam daleyGiacomo chiesiBerry company public relationsB corpChiesi groupHealth canadaGlobal rare diseasesChiesi global rareMore informationProduct monographBenefit corporationGlobal rare

Chiesi Global Rare Diseases Announces Approval of FERRIPROX™ MR Deferiprone Extended-Release Tablets in Canada

/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected.

United kingdomUnited statesGiacomo chiesiAdam daleyHealth canadaB corpBerry company public relationsChiesi groupGlobal rare diseasesChiesi global rareMore informationProduct monographBenefit corporationGlobal rare